Zoetis Zeroing In On China, Brazil
Newly spun-off from Pfizer, Zoetis has big plans for its animal health business in the emerging markets, says the company's CEO Juan Ramon Alaix.
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
